Instil Bio, Inc.(TIL)

Biotechnology · Dallas, TX

$6.89-0.07 (-0.94%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T21:18:27.571Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:18:27.571Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 46,693,905
TTM free cash flow · period ending 2026-06-30: -23,612,000

FMP input reference: 1639651ea08d8a43111aa8341d4d68762a5dc33ecadd1da8a92c037613eb041e

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

TIL Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

TIL Competitors' Price/FCF Ratio

TIL

Instil Bio, Inc.

Current

Market Cap

$46.69M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELU

Celularity Inc.

vs TIL

Market Cap

$45.73M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LITS

Lite Strategy, Inc.

vs TIL

Market Cap

$47.98M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

APLM

Apollomics, Inc.

vs TIL

Market Cap

$48.53M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HOWL

Werewolf Therapeutics, Inc.

vs TIL

Market Cap

$44.72M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SNWV

SANUWAVE Health Inc.

vs TIL

Market Cap

$44.71M

Price/FCF Ratio

10.54

TTM Avg

33.81

3Y Avg

4688.00

5Y Avg

4688.00

MBOT

Microbot Medical Inc.

vs TIL

Market Cap

$48.76M

Price/FCF Ratio

N/A

TTM Avg

13.23

3Y Avg

14.22

5Y Avg

14.22

TELA

TELA Bio, Inc.

vs TIL

Market Cap

$48.77M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SRTS

Sensus Healthcare, Inc.

vs TIL

Market Cap

$48.89M

Price/FCF Ratio

N/A

TTM Avg

62.26

3Y Avg

60.70

5Y Avg

63.54

POCI

Precision Optics Corporation, Inc.

vs TIL

Market Cap

$49.25M

Price/FCF Ratio

N/A

TTM Avg

99.30

3Y Avg

99.30

5Y Avg

93.30

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Instil Bio, Inc. (TIL)	$46.69M	N/A	N/A	N/A	N/A
Celularity Inc. (CELU)vs ›	$45.73M	N/A	N/A	N/A	N/A
Lite Strategy, Inc. (LITS)vs ›	$47.98M	N/A	N/A	N/A	N/A
Apollomics, Inc. (APLM)vs ›	$48.53M	N/A	N/A	N/A	N/A
Werewolf Therapeutics, Inc. (HOWL)vs ›	$44.72M	N/A	N/A	N/A	N/A
SANUWAVE Health Inc. (SNWV)vs ›	$44.71M	10.54	33.81	4688.00	4688.00
Microbot Medical Inc. (MBOT)vs ›	$48.76M	N/A	13.23	14.22	14.22
TELA Bio, Inc. (TELA)vs ›	$48.77M	N/A	N/A	N/A	N/A
Sensus Healthcare, Inc. (SRTS)vs ›	$48.89M	N/A	62.26	60.70	63.54
Precision Optics Corporation, Inc. (POCI)vs ›	$49.25M	N/A	99.30	99.30	93.30

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/FCF Ratio: N/A

TIL Price/FCF Ratio Metrics

TIL Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Related Metrics